Gerald has said previously that he will give Lympro revenue guidance during the 2Q conference call in August. Now correct me if I am wrong, but would we not have to have a partner already in order to come up with revenue guidance. We would have to be set up with some company in order to know their share of profits, royalties, etc.... in order to come up with a ballpark number. This means (in my opinion) that a partner should get announced before the 2Q conference call. What do you guys think?
P.S. Since we have to announce revenue guidance in 3 weeks, tomorrow would be a great day to do just that...
What does the partners share have to do with it? Revenue is revenue, that's like saying we need to wait to see what kind of overhead it will take? Nonsense revenue is revenue! Thought, with every 50 mil in revenue and with a 13X valuation the PPS would be .88..... As GC said maybe a R/S not necessary, maybe 250 mil in revenue like Watson said????
The partner's share is important in revenue. Let's say Amaranuts makes 50 million via LymPro the first year. If the partner's share is 10%, the revenue would be brought down to 45 million. If the partner's share is 20%, than the revenue would be brought down to 40 million. Royalties and partner's $$ are going to be an important part of revenue guidance. No one is going to work us for free.